Journals / Erciyes Tıp Dergisi / 2007 / Cilt: 29 - Sayı: 4

Osteoporozlu hastalarda paraoksonaz 1 aktivitesi ve malondialdehid düzeylerinin değerlendirilmesi

Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with osteoporosis

Pages
268–273
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

MCAD phenotype, because the disorder shows a strong founder effect and consanquinity very common in our population than other European countries.Results: We detected a G985 carrier frequency of 3 in 1400 Turkish population.The incidence of MCAD deficiency is lower in our population than other populations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Medium chain acyl-CoA dehydrogenase (MCAD) is a tetrameric flavoprotein essential for the beta-oxidation of medium chain fatty acids.
📊
Key Findings & Data:It is potentially fatal, but shows a wide clinical spectrum.The aim of the present study was to investigate the frequency of the G985A mutation carrier in the medium-chain acyl-CoA dehydrogenase (MCAD) gene in Turkish population.Material and Methods:We analyzed 1400 DNA samples.
💡
Conclusion & Impact:MCAD phenotype, because the disorder shows a strong founder effect and consanquinity very common in our population than other European countries.Results: We detected a G985 carrier frequency of 3 in 1400 Turkish population.The incidence of MCAD deficiency is lower in our population than other populations.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: Medium chain acyl-CoA dehydrogenase (MCAD) is a tetrameric flavoprotein essential for the beta-oxidation of medium chain fatty acids. MCAD deficiency is the most commonly recognized defect of mitochondrial b-oxidation. It is potentially fatal, but shows a wide clinical spectrum.The aim of the present study was to investigate the frequency of the G985A mutation carrier in the medium-chain acyl-CoA dehydrogenase (MCAD) gene in Turkish population.Material and Methods:We analyzed 1400 DNA samples. Mutation detection was performed with the polymerase chain reaction (PCR), in which a NcoI restriction site as created in the presence of a G985A mutation in the PCR product, followed by the digestion, and 8% polyacyrlamide gel electrophoresis.Conclusion: The present study suggest that different MCAD mutations responsible for Turkish Population. MCAD phenotype, because the disorder shows a strong founder effect and consanquinity very common in our population than other European countries.Results: We detected a G985 carrier frequency of 3 in 1400 Turkish population.The incidence of MCAD deficiency is lower in our population than other populations.

Özet

Amaç: Orta zincirli açil-CoA dehidrojenaz (MCAD) orta zincirli yağ asitlerinin beta oksidasyonu için elzem olan bir tetramerik flavoproteindir. MCAD eksikliği mitokondrial beta oksidasyon defektinin en sık bilinen nedenidir. Fatal olabilmekle beraber geniş bir klinik spektrumu vardır.Bu çalışmanın amacı MCAD genindeki G985A mutasyon taşıyıcısı sıklığını Türk popülasyonunda tesbit etmektir.Gereç ve Yöntemler: 1400 sağlıklı bireyden DNA örneği analiz edilmiştir. Mutasyon tesbiti polimeraz zincir reaksiyonu sonrası G985A mutasyonu taşıyan PCR ürününün NcoI restriksiyon bölgesine sahip olması ve kesim sonrası %8.lik poliakrilamid jelle görüntülenmesi suretiyle yapılmıştır. Bulgular:G985A heterozigot mutasyonu Türk popülasyonunda 1400 kişide 3 kişide tesbit edildi. Sonuç: G985A taşıyıcılığının düşük olması MCAD eksikliğinin insidansının Türk toplumunda G985A taşıyıcılığı diğer popülasyonlara göre düşüktür. Bu çalışma Türk toplumunda akraba evliliğinin Avrupa ülkelerine göre sık olması ve hastalığın birikim göstermesi nedeniyle Türk toplumunda MCAD eksikliğinden farklı mutasyonların sorumlu olabileceğini önermektedir

🔖

Cite This Article

KOÇER, D., BAŞKOL, G., DEMİR, H., BAŞKOL, M., ÇAVDAROĞLU, B. (2022). Osteoporozlu hastalarda paraoksonaz 1 aktivitesi ve malondialdehid düzeylerinin değerlendirilmesi. Erciyes Tıp Dergisi, Cilt: 29 - Sayı: 4, 268–273. https://ajindex.com/articles/502716

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Halliwell B, Gutteridge JM. Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet 1984; 23: 1396–1397. 2-Nohl H. Involvement of free radicals in ageing: a consequence or cause of senescence. Br Med Bull 1993; 49: 653–667. 3-Kasten TP, Collin-Osdoby P, Patel N, et al. Potentiation of osteoclast bone resorptive activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci USA 1994; 91: 3569–3573. 4-Silverton SF, Mesaros S. Osteoclast radical interactions: NADPH causes pulsatile release of NO and stimulates superoxide production. Endocrinology 1995; 136: 5244–5247. 5-Yang S, Ries WL, Key LL. NADP oxidase in the formation of superoxide in osteoclasts. Calcif Tissue Int 1998; 63: 346–350. 6-Mody N, Parhami F, Sarafian TA, Demer LL. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radical Biol Med 2001; 31: 509–516. 7-Raisz LG. The osteoporosis revoluation. Ann Intern Med 1997; 126: 458-462. 8-Gutteridge JM. Free radicals in disease processes: a compilation of cause and consequence. Free Radic Res Commun 1993; 19: 141-158. 9-Halliwell B. Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet 1994; 344; 721-724. 10-Gambhir JK, Lali P, Jain AK. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 1997; 30: 351-355. 11-Draper HH, Hadley M. A review of recent studies on the metabolism of exogenous and endogenous malondialdehyde. Xenobiotica 1990; 20: 901-907. 12-Romero FJ,Bosch Morell B, Romero MJ, et al. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect 1998; 106: 1229-1234. 13-Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000; 21: 115–137. 14-Parhami F, Morrow AD, Balucan J, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 1997; 17: 680–687. 15-Parhami F, Jackson SM, Le V, et al. Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 1999; 14: 2067–2078. 16-Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high-density lipoprotein ox